Article
Down-regulation of pseudogene Vimentin 2p is associated with poor outcome in de novo acute myeloid leukemia.
Cancer biomarkers : section A of Disease markers - 1 Jan 2017
Zhai Ling-Ling, Zhou Jiao, Zhang Jing, Tang Xi, Zhou Ling-Yu, Yin Jia-Yu, Vanessa Minse-Evola Deniz, Peng Wen, Lin Jiang, Deng Zhao-Qun
Abstract excerpt
OBJECTIVES: This study was intended to investigate the expression status of Vimentin 2p (VIM 2p), a pseudogene of Vimentin, and further analyze its clinical significance in AML patients. METHODS: Real-time quantitative PCR (RQ-PCR) was employed to explore the expression status of VIM 2p in 128 patients with de novo AML and 36 healthy controls. RESULTS: The expression level of VIM 2p was significantly decreased...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.